Mohamed Hashish

• Lead HIV Sales and Marketing organization while drive cross functional collaboration across Commercial, Medical, Market Access, COMEX, supply, and other functions to ensure growth of HIV business.
• This role requires also high-level collaboration within matrix design to align with Viiv EM/International teams to ensure alignment as a focal point in Saudi Arabia
• Key achievements in current role: YoY growth achieving CAGR of >20% and ~50% growth in patient numbers.
• Accelerate tender demand with a result of 30% additional quantity as upside vs Tender award.
• Dovato launch readiness in Ministry of Health while working to issue 1st tender Purchase order.
• Dovato successful launch in trade sector.
• Evaluated employee performance and conveyed constructive feedback to improve skills.
• Successfully managed budgets and allocated resources to maximize productivity and profitability.
• Cultivated positive rapport with fellow employees to boost company morale and promote employee retention.
• Established performance goals for employees and provided feedback on methods for reaching those milestones.

Talent development:

• Introduce the 1st Saudi FLSL to the organization.
• Recruited, interviewed and hired employees and implemented mentoring program to promote positive feedback and engagement.
• Develop the 1st Team leader role for Saudi talents as a successful pilot which expanded to cover all BUs.
• Increased efficiency by implementing new business unit strategies and streamlining operations.
• Developed strong team dynamics through regular communication, resulting in improved performance.

• Led Respi Marketing team to develop and implementation of commercial strategy and operational plan time and within budget.
• Led Classic Respi brand teams which contributed to around 30% of GSK Saudi turnover

Key achievements in this role:

• New ICS/LABA strategy development and excellence execution of PRD
• Leading Seretide Revamping plan is Saudi to gain 7% MS
• Support development of key marketing talents
• Participating in DRM team to achieve CCC (Core Commercial Cycle) Level II for Saudi Arabia with significant improvement in Forecast Accuracy
• Core team member in Global Co-creation for Classic Respiratory
• Leading Classic Respi brand teams which contributed to around 30% of GSK Saudi turnover
• Lead NBA project for Seretide in Saudi achieving utilization rate > regional average

Extended Responsibility to lead CEP Marketing Team for 6 Months (July-December-2019),

• Led a team of 3 Marketing Managers, 2 Customers Managers and 2 Part-time project leaders with key accountability on Business planning, Financials planning, Marketing execution and deliverables for CEP BU.

• Leading marketing deliverables of Seretide, Flixotide & Ventolin in GCC Countries (Leading co-creation of strategy & Campaigns), this role included one Product Manager as direct report.

• Leading marketing deliverables for Relvar & Seretide in Adult indication for GCC Countries (Saudi Arabia, UAE, Kuwait, Bahrain, Oman & Qatar) leading the planned 3% MS gain for Relvar & Rebuilding strategic focus behind Seretide through launching two new strategic initiatives; Leading the development of two marketing associates as direct reports from FLP
• Main achievement in GCC Marketing roles: Grow MS% of Seretide in Saudi since 2018 and regaining GSK's leadership position across ICS/LABA market
• Develop talent and capability of my direct reports (Brand manager & FLP associates) within the last 3 years
• Achieving the highest Market share for Relvar across EMs by July 2017
• Developed 1st Relvar RACE based detailing aid which had been selected as best practice among MENA-CIS and presented to CEO
• Successfully launched Relvar in all GCC markets within planned timelines
• Achieved all 100 Days Launch KPIs.

• Lead GSK respiratory innovative portfolio launches in KSA including two new brands, Relvar & Anoro for bronchial asthma & COPD.
• Collaborated with sales, medical, and support teams to launch products on time and within budget.
• Conducted market research to identify new opportunities and target markets.
• Monitored market trends and competitor performance to update promotional strategies.
• Launched successful digital marketing campaigns that achieved goals for increased website traffic.

• Leading GSK classic respiratory portfolio in KSA to be Number One in the Respiratory market and Seretide to lead the total Saudi market by £37 M
• Lead Brand extended team, DCP educational project to enhance the skills and performance of Respiratory team.

• Treatment evolution plan specialist, specialist role is to support & drive growth of the COPD evolution and market development in KSA through F2F detailing, Respiratory educators train the trainers activities and Spirometry screening days
• (Jan 2013- Sept 13) Executive Medical Representative: Responsible for the promotion of Respiratory Portfolio in the Institution Sector Western region
• (June 2009 - Jan 2013) Responsible for the promotion of Anti-Infective/Allergy Portfolio in the Private Sector, Western middle region
• (March 2005 - May 2009)